ENANTA PHARMACEUTICALS, INC
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2011 | $41.9M | $25.3M | $23.3M |
| FY2012 | $41.7M | $21.3M | $21.4M |
| FY2013 | $32.1M | $9.0M | $9.6M |
| FY2014 | $47.7M | $19.0M | $34.4M |
| FY2015 | $160.9M | $124.1M | $79.0M |
| FY2016 | $88.3M | $30.8M | $21.7M |
| FY2017 | $102.8M | $24.6M | $17.7M |
| FY2018 | $206.6M | $88.3M | $72.0M |
| FY2019 | $205.2M | $36.7M | $46.4M |
| FY2020 | $122.5M | $-41.6M | $-36.2M |
| FY2021 | $97.1M | $-109.6M | $-79.0M |
| FY2022 | $86.2M | $-123.8M | $-121.8M |
| FY2023 | $79.2M | $-137.2M | $-133.8M |
| FY2024 | $67.6M | $-121.7M | $-116.0M |
| FY2025 | $65.3M | $-85.3M | $-81.9M |